Evidence map›Paper›PMID 33967977›Full record

ArticleFrontiers in microbiology2021

Green Synthesized Silver Nanoparticles: Antibacterial and Anticancer Activities, Biocompatibility, and Analyses of Surface-Attached Proteins.

Magdalena Wypij, Tomasz Jędrzejewski, Joanna Trzcińska-Wencel, Maciej Ostrowski, Mahendra Rai, Patrycja Golińska

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 248 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Prevention and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  8. Green-SynthesizedJournal of functional biomaterials · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Magdalena WypijDepartment of Microbiology, Nicolaus Copernicus University, Toruń, Poland.
Tomasz JędrzejewskiDepartment of Immunology, Nicolaus Copernicus University, Toruń, Poland.
Joanna Trzcińska-WencelDepartment of Microbiology, Nicolaus Copernicus University, Toruń, Poland.
Maciej OstrowskiDepartment of Biochemistry, Nicolaus Copernicus University, Toruń, Poland.
Mahendra RaiDepartment of Microbiology, Nicolaus Copernicus University, Toruń, Poland.
Patrycja GolińskaDepartment of Microbiology, Nicolaus Copernicus University, Toruń, Poland.
Nicolaus Copernicus University · PLSant Gadge Baba Amravati University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing number of multi-drug-resistant bacteria and cancer cases, that are a real threat to humankind, forces research world to develop new weapons to deal with it. Biogenic silver nanoparticles (AgNPs) are considered as a solution to this problem. Biosynthesis of AgNPs is regarded as a green, eco-friendly, low-priced process that provides small and biocompatible nanostructures with antimicrobial and anticancer activities and potential application in medicine. The biocompatibility of these nanoparticles is related to the coating with biomolecules of natural origin. The synthesis of AgNPs from actinobacterial strain was confirmed using UV-Vis spectroscopy while their morphology, crystalline structure, stability, and coating were characterized using, transmission electron microscopy (TEM), X-ray diffraction (XRD), Zeta potential and Fourier transform infrared spectroscopy (FTIR). Antibacterial activity of biogenic AgNPs was evaluated by determination of minimum inhibitory and minimum biocidal concentrations (MIC and MBC) against

Indexed as

antibacterial agentanticancer agentbiogenic AgNPscapping agentscytotoxicityMCF-7protein moleculesRAW 264.7

Identifiers

PMID33967977
PMCPMC8100210
OpenAlexW3160763916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.